Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-Guided Tamoxifen Dosing in Breast Cancer
NCT00764322Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jun 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, ductal carcinoma in situ (DCIS), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Jun 2008; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancerductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT00764322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764322.